🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- H00263105
- Market Cap
- Small Cap
- IPO
- 9/22/2016 · $11.00/share
Business: AC Immune SA is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins.
Company Contact
- CEO
- Andrea Pfeifer, Ph.D.
- CFO
- Christopher Roberts
- Investor Relations
- Corey Davis, LifeSci Advisors · 212-915-2577 · cdavis@lifesciadvisors.com